Ji Won Chung

Title: Ji Won Chung - Innovator in Antigen-Binding Molecules

Introduction

Ji Won Chung is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of antigen-binding molecules. With a total of 2 patents, his work is paving the way for advancements in cancer treatment.

Latest Patents

Ji Won Chung's latest patents focus on chimeric antigen receptors that bind to HLA-DR and CAR-T cells. The inventions relate to antigen-binding molecules that include specific heavy and light chain variable regions. These regions comprise complementarity-determining regions with defined amino acid sequences. The technology aims to enhance T cell receptor functionality and includes a cell line expressing these innovative molecules.

Career Highlights

Ji Won Chung is currently employed at Eutilex Co., Ltd., where he continues to push the boundaries of medical research. His expertise in antigen-binding technology has positioned him as a key player in the biotechnology sector.

Collaborations

Some of his notable coworkers include Byoung S Kwon and Young Ho Kim, who contribute to the collaborative efforts in their research projects.

Conclusion

Ji Won Chung's innovative work in antigen-binding molecules is making a significant impact in the field of biotechnology. His patents reflect a commitment to advancing cancer therapies and improving patient outcomes.